Hormonal changes often trigger stubborn weight gain, shifts in body composition, and a higher risk of cardiovascular disease
Three pathways still qualify a patient: a documented allergy to an inactive ingredient in the approved product, a dose or route not commercially available such as a microdose below 2.5 mg, or a clinically meaningful combination such as tirzepatide with niacinamide or B12
Upon discontinuation, most patients regain all lost weight within 6 months because phentermine does not address the underlying metabolic dysfunction that caused obesity
For the broader picture of which peptides ARE FDA approved, see our FDA Approved Peptides List 2026
Whitlock RH, Chartier M, Komenda P, Hingwala J, Rigatto C, Walld R, et al
Share recent results, or well help you get them through Quest or Labcorp